Monika Maas Enriquez

Intravenous immunoglobulin in secondary progressive multiple sclerosis: randomised placebo-controlled trial

O. R. Hommes, Per Soelberg Sørensen, Franz Fazekas et al. · The Lancet · 2004 · 183 citations

Life Sciences, Immunology, Neurology +10

Efficacy and safety of secondary prophylactic vs. on‐demand sucrose‐formulated recombinant factor VIII treatment in adults with severe hemophilia A: results from a 13‐month crossover study

Peter W. Collins, A. Faradji, Massimo Morfini et al. · Journal of Thrombosis and Haemostasis · 2009 · 140 citations

Medicine, Hematology, Pharmacotherapy +11

Prophylaxis vs. on‐demand treatment with BAY 81‐8973, a full‐length plasma protein‐free recombinant factor VIII product: results from a randomized trial (LEOPOLD II)

Renchi Yang, L. Rusen, H. Beckmann et al. · Journal of Thrombosis and Haemostasis · 2014 · 88 citations · Full text

Medicine, Hematology, Pharmacotherapy +13

Peripheral deposition of α₁‐protease inhibitor using commercial inhalation devices

Peter Brand, H. Beckmann, Monika Maas Enriquez et al. · European Respiratory Journal · 2003 · 71 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacotherapy +15

Efficacy and safety of BAY 81‐8973, a full‐length recombinant factor VIII: results from the LEOPOLD I trial

Kapil Saxena, Shadan Lalezari, Johannes Oldenburg et al. · Haemophilia · 2016 · 55 citations · Full text

Medicine, Hematology, Pharmacotherapy +16